These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8061340
41. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Adachi K, Kumamoto T, Araki S. Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855 [Abstract] [Full Text] [Related]
42. [Serum immunoreactive trypsin in chronic pancreatitis patients]. Tŭrkolev N, Brailski Kh, Mendizova A. Vutr Boles; 1985 Nov; 24(1):36-40. PubMed ID: 4024607 [Abstract] [Full Text] [Related]
43. [Soluble interleukin-2 receptor level in the sera and ascitic fluids in patients with ovarian cancer]. Pu FR, Cheng SW, Zhu D. Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):478-80, 511. PubMed ID: 7835120 [Abstract] [Full Text] [Related]
44. [The serum level of the secreted interleukin 2 receptor (sIL-2R): a lymphocyte activity parameter in sarcoidosis]. Müller-Quernheim J, Strausz J, Ferlinz R. Pneumologie; 1990 Feb; 44 Suppl 1():213-4. PubMed ID: 2367367 [Abstract] [Full Text] [Related]
46. Serum beta 2-microglobulin in chronic diseases of the pancreas. Pezzilli R, Billi P, Fiocchi M, Beltrandi E, Cappelletti O, Sprovieri G, Miglioli M. Int J Pancreatol; 1995 Apr; 17(2):161-6. PubMed ID: 7622938 [Abstract] [Full Text] [Related]
47. [Diagnostic value of serum angiopoietin-2 level in pancreatic cancer]. Wan RG, Chen DB, Lou YG, Wang MF, Zhang QH, Jin DX, Zhou SH. Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):47-9. PubMed ID: 21575464 [Abstract] [Full Text] [Related]
48. Serum adenosine deaminase levels in pancreatic diseases. Ibiş M, Köklü S, Yilmaz FM, Başar O, Yilmaz G, Yüksel O, Yildirim E, Oztürk ZA. Pancreatology; 2007 Jan; 7(5-6):526-30. PubMed ID: 17901713 [Abstract] [Full Text] [Related]
49. Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer. Correlation with clinical activity. Ginns LC, De Hoyos A, Brown MC, Gaumond BR. Am Rev Respir Dis; 1990 Aug; 142(2):398-402. PubMed ID: 2200317 [Abstract] [Full Text] [Related]
50. Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Pezzilli R, Barassi A, Corsi MM, Morselli-Labate AM, Campana D, Casadei R, Santini D, Corinaldesi R, D'Eril GM. Scand J Gastroenterol; 2010 Aug; 45(1):93-9. PubMed ID: 19883273 [Abstract] [Full Text] [Related]
51. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer. Wu LJ, Chen KY, Chi KH, Chen SY, Liang MJ, Shiau CY, Wang LW, Liu YM, Chow KC, Yen SH. Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289 [Abstract] [Full Text] [Related]
52. Serum procarboxypeptidase A and carboxypeptidase A levels in pancreatic disease. Kemik O, Kemik AS, Sumer A, Beğenik H, Dülger AC, Purisa S, Tuzun S. Hum Exp Toxicol; 2012 May; 31(5):447-51. PubMed ID: 21502183 [Abstract] [Full Text] [Related]
53. Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer? Gullo L, Pezzilli R, Ventrucci M, Lesi C, Zoni L, D'Ambrosi A, Alvisi V. Pancreas; 1989 May; 4(3):335-8. PubMed ID: 2734276 [Abstract] [Full Text] [Related]
54. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay. Oguchi H, Homma T, Kawa S, Nagata A, Furuta S, Fukui H. Cancer Detect Prev; 1984 May; 7(1):51-8. PubMed ID: 6367984 [Abstract] [Full Text] [Related]
55. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer? Kayhan B, Kayhan B, Akdoğan M. Int J Biol Markers; 2004 May; 19(3):196-202. PubMed ID: 15503821 [Abstract] [Full Text] [Related]